• Company
  • News
  • Product groups
    • Galileo® Training devices
    • Galileo® therapy system
    • xelerate.you
    • Leonardo Mechanograph
    • pQCT
  • Literature
    • Literature
    • Factsheets
  • About us
    • Distributors Worldwide
    • Cooperations and references
      • Competitive sports
      • Paediatrics
      • Pyhsiotherapy & Medicine
      • Veterinary Medicine
      • Space research
    • Research projects
    • Events
    • Company history
    • Our Mission
    • Jobs
  • Service
    • Contact us
    • Service Training and Support
    • Service form
    • Location finder
    • Downloads
    • My account
    • Support-Session
CALL NOW

+49 7231 15448 30

DO YOU HAVE ANY QUESTIONS?

To contact form

Search
  • German
  • English
Menu
  • German
  • English
  • Galileo Training
  • Galileo Therapy
  • xelerate.you
  • Leonardo Mechanography
  • Stratec PQCT
t2023est22nut0ss5zer
20 Jan 2025
20. January 2025

Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats

Prostaglandin E(2) (PGE(2)) is essential for fracture healing. Systemic administration of EP4 ligands such as PGE(2) and other syntheti...
Continue reading
t2023est22nut0ss5zer
20 Jan 2025
20. January 2025

Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis

Mutations in the fibroblast growth factor 23 gene, FGF23, cause autosomal dominant hypophosphatemic rickets (ADHR). The gene product, F...
Continue reading
t2023est22nut0ss5zer
20 Jan 2025
20. January 2025

The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice

Previous studies have associated activation of canonical Wnt signaling in osteoblasts with elevated bone formation. Here we report that...
Continue reading
t2023est22nut0ss5zer
20 Jan 2025
20. January 2025

Mice deficient in 11beta-hydroxysteroid dehydrogenase type 1 lack bone marrow adipocytes, but maintain normal bone formation

Glucocorticoids (GCs) exert potent, but poorly characterized, effects on the skeleton. The cellular activity of GCs is regulated at a p...
Continue reading
t2023est22nut0ss5zer
20 Jan 2025
20. January 2025

Long-term treatment of lasofoxifene preserves bone mass and bone strength and does not adversely affect the uterus in ovariectomized rats

The purpose of this study was to determine the long-term effects of lasofoxifene, a new selective estrogen receptor modulator, on bone ...
Continue reading
t2023est22nut0ss5zer
20 Jan 2025
20. January 2025

Effects of hypophysectomy and recombinant human growth hormone on material and geometric properties and the pre- and post-yield behavior of femurs in young rats

To study the musculoskeletal effects of hypophysectomy (Hx) and a partial replacement treatment with recombinant human growth hormone (...
Continue reading
t2023est22nut0ss5zer
20 Jan 2025
20. January 2025

Effects of loss of steroid receptor coactivator-1 on the skeletal response to estrogen in mice

Steroid receptor coactivator (SRC)-1 is an important nuclear receptor coactivator that enhances estrogen (E) action in many tissues, bu...
Continue reading
t2023est22nut0ss5zer
20 Jan 2025
20. January 2025

Precision and accuracy of DXA and pQCT for densitometry of the rat femur

Measurements of bone mineral density and bone mineral content are key data in the study of osteoporosis and pathologic skeletal disease...
Continue reading
t2023est22nut0ss5zer
20 Jan 2025
20. January 2025

Biglycan deficiency interferes with ovariectomy-induced bone loss

Biglycan is a matrix proteoglycan with a possible role in bone turnover. In a 4-week study with sham-operated or OVX biglycan-deficient...
Continue reading
t2023est22nut0ss5zer
20 Jan 2025
20. January 2025

Disabling of receptor activator of nuclear factor-kappaB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivo

The tumor necrosis factor family ligand, tumor necrosis factor-related activation-induced cytokine (TRANCE), and its receptors, recepto...
Continue reading
Load more posts
Loading...

The verdict of our customers: Excellent

 4.7/5

4.7 out of 5 stars based on 868 reviews

TÜV certified

We are a TÜV certified manufacturer for medical products.

Made in Germany

Development and manufacturing in Germany.

Proven quality

10 years service guarantee & more than 35 years experience in the company group.

Research studies

over 2000 scientific publications about our products.

Active worldwide

Internationally active with our distribution partners.

  • +49 7231 15448 30
  • info@novotecmedical.de

Product groups

  • Galileo Training
  • Galileo Therapy
  • xelerate
  • Leonardo Mechanograph
  • pQCT

Service

  • Service form
  • Location finder
  • Service Training and support
  • Login

About us

  • Company history
  • Events
  • Research projects
  • Cooperations & References
  • Distributors worldwide
  • Jobs

Imprint

Privacy policy

General terms and conditions

© 2008-2025 Novotec Medical GmbH

Start typing to see posts you are looking for.
Close
  • Company
  • News
  • Product groups
    • Galileo® Training devices
    • Galileo® therapy system
    • xelerate.you
    • Leonardo Mechanograph
    • pQCT
  • Literature
    • Literature
    • Factsheets
  • About us
    • Distributors Worldwide
    • Cooperations and references
      • Competitive sports
      • Paediatrics
      • Pyhsiotherapy & Medicine
      • Veterinary Medicine
      • Space research
    • Research projects
    • Events
    • Company history
    • Our Mission
    • Jobs
  • Service
    • Contact us
    • Service Training and Support
    • Service form
    • Location finder
    • Downloads
    • My account
    • Support-Session
  • Flag for English English
    • Flag for English Deutsch
  • Telefon: +49 7231 15448 30
  • Email: Info@novotecmedical.de
  • News
  • Standortfinder
  • Phone: +49 7231 15448 30
  • Email: Info@novotecmedical.de
  • News
  • Location finder